SCHEMBL14280878

SCHEMBL14280878

CC(C)C(N)c1cn(-c2ccccc2)c(=O)n1Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ KMT2A Q03164 2/20 0.41
▸ RGS4 P49798 4/20 0.41
▸ RGS8 P57771 4/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ LGMN Q99538 1/20 0.40
▸ GSK3A P49840 3/20 0.39
▸ GSK3B P49841 3/20 0.39
▸ CCNB2 O95067 1/20 0.39
▸ CDK1 P06493 1/20 0.39
▸ CCNB1 P14635 1/20 0.39
▸ CCNB3 Q8WWL7 1/20 0.39
▸ MAPK8 P45983 1/20 0.39
▸ MAPK9 P45984 1/20 0.39
▸ PGR P06401 1/20 0.39
▸ TLR7 Q9NYK1 2/20 0.38
▸ ADORA3 P0DMS8 1/20 0.38
▸ ADORA2B P29275 1/20 0.38
▸ PRKCA P17252 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14280870 0.86 RGS4 (0.43) HPGDCYP3A4KMT2ARGS4RGS8
SCHEMBL4490611 0.73 ROCK2 (0.53) HPGDCYP3A4KMT2ARGS4RGS8
SCHEMBL13963463 0.70 HPGD (0.43) HPGDCYP3A4KMT2ALGMNGSK3A
SCHEMBL30272686 0.68 HPGD (0.50) HPGDCYP3A4KMT2ARGS4RGS8
SCHEMBL5864333 0.68 PTGS1 (0.49) HPGDCYP3A4MAPK8MAPK9KDM4E
SCHEMBL8985073 0.67 GSK3B (0.67) HPGDCYP3A4KMT2ARGS4RGS8
SCHEMBL14563447 0.67 ALDH1A1 (0.47) HPGDCYP3A4KMT2AALDH1A1GSK3A
SCHEMBL3940708 0.66 HPGD (0.64) HPGDCYP3A4KMT2AALDH1A1LGMN
SCHEMBL14408874 0.66 KDM4E (0.47) HPGDCYP3A4KMT2AALDH1A1GSK3A
SCHEMBL3319539 0.65 HDAC8 (0.44) KMT2AALDH1A1KDM4ERAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080021079-A1 Compounds, Compositions, and Methods CYTOKINETICS, INC. 2008-01-24 — — US disclosed
US-20080021079-A1 Compounds, Compositions, and Methods CYTOKINETICS, INC. 2008-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021079-A1 Compounds, Compositions, and Methods ALPP, PCNA, MKI67 HPGD 921/4885CYP3A4 4656/4885KMT2A 2245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback